Product Information

POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1351 per EA under NDC 62037072010. Its NADAC has been published 218 times since Nov 28, 2013.

FDA first approved this application on Apr 10, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 20 MEQ TABLET

Potassium Chloride
$0.1351per EA

Strength

20 meq/1

NDC

62037072010

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075604

FDA Approved

4/10/2002

TE Code

AB1

On Market Since

4/10/2002

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 218 times since Nov 28, 2013, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1351 per EA
All-time high$0.2909 (Dec 11, 2013)
All-time low$0.1196 (Jul 17, 2024)
52-week high$0.1502
52-week low$0.1333
Median price$0.1481
Average price$0.1816
Largest weekly change-32.3% (Aug 30, 2023)
Weeks tracked218
Tracking sinceNov 28, 2013

Price History

1W

+1.3%

1M

+1.3%

3M

-1.2%

6M

-0.6%

1Y

-10.1%

3Y

-48.0%

5Y

-48.0%

All

-53.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Actavis Pharma, Inc., is $0.1351 per EA (NDC 62037072010), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 53.6%. It has been tracked across 218 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?

Since Nov 28, 2013, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1196 (Jul 17, 2024) to a high of $0.2909 (Dec 11, 2013), with a median of $0.1481 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 20 MEQ TABLET, is $0.1196 per EA — about 11% below POTASSIUM CL ER 20 MEQ TABLET.

Who manufactures POTASSIUM CL ER 20 MEQ TABLET?

POTASSIUM CL ER 20 MEQ TABLET (NDC 62037072010) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.